M. Bamji

发表

Improved specificity of in vitro anti-HIV antibody production: implications for diagnosis and timing of transmission in infants born to HIV-seropositive mothers.

N. Chirmule, E. Abrams, N. Oyaizu, 1994, AIDS research and human retroviruses.

Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.

S. Lee, P. Krogstad, S. Nachman, 2000, AIDS research and human retroviruses.

Longitudinal changes in regional fat content in HIV-infected children and adolescents

M. Purswani, E. Abrams, S. Arpadi, 2009, AIDS.

Body composition in prepubertal children with human immunodeficiency virus type 1 infection.

J. Wang, M. Horlick, D. Kotler, 1998, Archives of pediatrics & adolescent medicine.

Effect of Bimonthly Supplementation With Oral Cholecalciferol on Serum 25-Hydroxyvitamin D Concentrations in HIV-Infected Children and Adolescents

E. Shane, D. McMahon, M. Purswani, 2009, Pediatrics.

Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.

L. Mofenson, V. Bonagura, P. Edelson, 1991, The New England journal of medicine.

Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children.

J. Wang, R. Pierson, D. Matthews, 2000, The Journal of nutrition.

Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission

N. Shaffer, P. Thomas, G. Schochetman, 1991 .

Dynamics of maternal IgG antibody decay and HIV-specific antibody synthesis in infants born to seropositive mothers. The NYC Perinatal HIV Transmission Study Group.

N. Shaffer, P. Thomas, G. Schochetman, 1993, AIDS research and human retroviruses.

Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.

N. Shaffer, P. Thomas, G. Schochetman, 1991, AIDS (London).

Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy

S. Spector, L. Aurpibul, J. Currier, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Low risk of mother-to-child transmission of human T lymphotropic virus type II in non-breast-fed infants. The NYC Perinatal HIV Transmission Collaborative Study.

T. M. Hartley, N. Shaffer, E. Abrams, 1992, The Journal of infectious diseases.

Pediatric AIDS: Clinical, Pathologic, and Basic Science Perspectives. Conference proceedings. Washington, D.C., November 18-21, 1992.

Boechat, R. Elashoff, R. Mellins, 1993, Annals of the New York Academy of Sciences.

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study.

R. Steketee, D. Thea, L. Kuhn, 1999, The Journal of infectious diseases.

Effect of Bimonthly Supplementation With Oral Cholecalciferol on Serum 25-Hydroxyvitamin D Concentrations in HIV-Infected Children and Adolescents

E. Shane, D. McMahon, M. Purswani, 2009, Pediatrics.

Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group.

M. Kalish, D. Thea, T. Brown, 1997, The Journal of pediatrics.